GlassScriptPhysician profile
Torin Karsonovich
NPI 1770931297
$1,359.42
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2021: $20.72 · 2022: $325 · 2023: $39.63 · 2024: $125 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $294.23 | 2022-2025 | Strata |
| Medical Device Business Services, INC. | $289.98 | 2019 | |
| Neuropace, INC. | $157.41 | 2024-2025 | |
| Karl Storz Endoscopy-America | $139.81 | 2019 | |
| Stryker Corporation | $115.50 | 2022 | |
| Nuvasive, INC. | $115.39 | 2019 | |
| Davol INC. | $98.07 | 2021-2023 | Bard 3dmax Mesh |
| Zimmer Biomet Holdings, INC. | $53.90 | 2019 | |
| Medtronic USA, INC. | $49.85 | 2019 | |
| Integra Lifesciences Corporation | $24.57 | 2023 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Arbor Pharmaceuticals, INC. | $20.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torin Karsonovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.